FOX CHASE CANCER CENTER
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1904-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.foxchase.org
Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab
- Conditions
- Interventions
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2021-10-08
- Lead Sponsor
- Fox Chase Cancer Center
- Registration Number
- NCT04677361
HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma
- First Posted Date
- 2020-12-16
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT04668768
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer
- First Posted Date
- 2020-11-06
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT04618809
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸Temple University Hospital, Philadelphia, Pennsylvania, United States
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
- Conditions
- Interventions
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 1100
- Registration Number
- NCT04557423
- Locations
- 🇺🇸
Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, United States
A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer
- Conditions
- Interventions
- First Posted Date
- 2020-08-10
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 81
- Registration Number
- NCT04506554
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸UT Southwestern Medical Center, Dallas, Texas, United States
Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer
- First Posted Date
- 2020-06-30
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT04452357
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
nCLE For Diagnosis Of Peripheral Lung Nodules By Robotic Navigational Bronchoscopy
- Conditions
- Interventions
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT04441749
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇳🇱Amsterdam University Medical Center, Amsterdam, AZ, Netherlands
Phase I Study in Advanced Malignancies With 5-ALA
- First Posted Date
- 2020-05-11
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 130
- Registration Number
- NCT04381806
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
- Conditions
- Interventions
- First Posted Date
- 2020-05-08
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 46
- Registration Number
- NCT04379999
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography
- Conditions
- Interventions
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2020-03-02
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 160
- Registration Number
- NCT04290585
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States